Chen Wangxue, Shen Hua, Webb Ann, KuoLee Rhonda, Conlan J Wayne
National Research Council Canada, Institute for Biological Sciences, Ottawa, Ont., Canada K1A 0R6.
Vaccine. 2003 Sep 8;21(25-26):3690-700. doi: 10.1016/s0264-410x(03)00386-4.
In order to begin understanding the immunological basis for immunity to tularemia, and to establish a baseline for judging the efficacy of potential novel vaccines, the present study examined the ability of the live vaccine strain of Francisella tularensis (F. tularensis) LVS, to elicit immunity in mice against subsequent systemic and aerosol challenge with highly virulent strains of the pathogen. The results show, that infection with LVS protects BALB/c mice against systemic challenge with virulent Types A and B F. tularensis. In contrast, C57BL/6 mice vaccinated with LVS were only rendered immune to systemic challenge with Type B F. tularensis. Neither mouse strain immunized with LVS was able to resist aerosol challenge with Type A F. tularensis, and only immunized BALB/c mice withstood exposure to aerosols of Type B F. tularensis.
为了开始理解兔热病免疫的免疫学基础,并建立一个判断潜在新型疫苗效力的基线,本研究检测了土拉弗朗西斯菌(F. tularensis)LVS活疫苗株在小鼠中引发免疫以抵抗随后该病原体高毒力菌株的全身感染和气溶胶攻击的能力。结果表明,LVS感染可保护BALB/c小鼠抵抗A、B型毒力土拉弗朗西斯菌的全身感染。相比之下,接种LVS的C57BL/6小鼠仅对B型土拉弗朗西斯菌的全身感染产生免疫。两种品系的小鼠接种LVS后均无法抵抗A型土拉弗朗西斯菌的气溶胶攻击,只有接种疫苗的BALB/c小鼠能够耐受B型土拉弗朗西斯菌气溶胶的暴露。